These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 3291903)
21. The impact of tumor cell proliferation in radioimmunotherapy. O'Donoghue JA Cancer; 1994 Feb; 73(3 Suppl):974-80. PubMed ID: 8306287 [TBL] [Abstract][Full Text] [Related]
22. Modelling of post-irradiation accelerated repopulation in squamous cell carcinomas. Marcu L; van Doorn T; Olver I Phys Med Biol; 2004 Aug; 49(16):3767-79. PubMed ID: 15446804 [TBL] [Abstract][Full Text] [Related]
23. Heterogeneity in the fractionation sensitivities of human tumor cell lines: studies in a three-dimensional model system. Stuschke M; Budach V; Stüben G; Streffer C; Sack H Int J Radiat Oncol Biol Phys; 1995 May; 32(2):395-408. PubMed ID: 7751182 [TBL] [Abstract][Full Text] [Related]
24. Impact of tumor repopulation on radiotherapy planning. Wang JZ; Li XA Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):220-7. PubMed ID: 15629615 [TBL] [Abstract][Full Text] [Related]
25. Dose equivalents of tumour repopulation during radiotherapy: the potential for confusion. Dale RG; Jones B; Sinclair JA Br J Radiol; 2000 Aug; 73(872):892-4. PubMed ID: 11026867 [TBL] [Abstract][Full Text] [Related]
26. The relative significance of repopulation and hypoxic clonogens in the fractionated radiotherapy of a mouse tumor. Urano M; Nishimura Y; Yaes R Radiat Res; 1995 May; 142(2):204-11. PubMed ID: 7724736 [TBL] [Abstract][Full Text] [Related]
27. Repopulation of cancer cells during therapy: an important cause of treatment failure. Kim JJ; Tannock IF Nat Rev Cancer; 2005 Jul; 5(7):516-25. PubMed ID: 15965493 [TBL] [Abstract][Full Text] [Related]
28. A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation. Prokopiou S; Moros EG; Poleszczuk J; Caudell J; Torres-Roca JF; Latifi K; Lee JK; Myerson R; Harrison LB; Enderling H Radiat Oncol; 2015 Jul; 10():159. PubMed ID: 26227259 [TBL] [Abstract][Full Text] [Related]
29. Time-dose factors in radiotherapy: a review of the human data. Thames HD; Bentzen SM; Turesson I; Overgaard M; Van den Bogaert W Radiother Oncol; 1990 Nov; 19(3):219-35. PubMed ID: 2281152 [TBL] [Abstract][Full Text] [Related]
30. Inclusion of molecular biotherapies with radical radiotherapy: modeling of combined modality treatment schedules. Jones B; Dale RG Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1025-34. PubMed ID: 10571212 [TBL] [Abstract][Full Text] [Related]
31. Investigating the effect of cell repopulation on the tumor response to fractionated external radiotherapy. Stavreva NA; Stavrev PV; Warkentin B; Fallone BG Med Phys; 2003 May; 30(5):735-42. PubMed ID: 12772979 [TBL] [Abstract][Full Text] [Related]
32. Rapid repopulation in radiotherapy: a debate on mechanism. Accelerated repopulation in tumours and normal tissues. Trott KR; Kummermehr J Radiother Oncol; 1991 Nov; 22(3):159-60. PubMed ID: 1771255 [TBL] [Abstract][Full Text] [Related]
33. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Withers HR; Taylor JM; Maciejewski B Acta Oncol; 1988; 27(2):131-46. PubMed ID: 3390344 [TBL] [Abstract][Full Text] [Related]
34. The influence of cell proliferation in tumours and normal tissues during fractionated radiotherapy. Dutreix J; Tubiana M; Wambersie A; Malaise E Eur J Cancer (1965); 1971 May; 7(2):205-13. PubMed ID: 5089998 [No Abstract] [Full Text] [Related]
35. [Rational dose fractionation schedule 1. Each fractional dose]. Masuda K; Matsuura K; Miyoshi M; Uehara T Gan No Rinsho; 1985 Sep; 31(12):1520-4. PubMed ID: 4079040 [TBL] [Abstract][Full Text] [Related]